Formulation Optimization, and Evaluation of Niosomal Nanocarriers for Enhanced Topical Delivery of Cetirizine

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2023 Aug 31

PMID 37649675

Authors

Mohammed F Aldawsari

El-Sayed Khafagy

Ehssan H Moglad

Amr Selim Abu Lila

Affiliations

Soon will be listed here.

Abstract

Cetirizine hydrochloride (CTZ), a second-generation anti-histaminic drug, has been recently explored for its effectiveness in the treatment of alopecia. Niosomes are surfactant-based nanovesicular systems that have promising applications in both topical and transdermal drug delivery. The aim of this study was to design topical CTZ niosomes for management of alopecia. Thin film hydration technique was implemented for the fabrication of CTZ niosomes. The niosomes were examined for vesicle size, surface charge, and entrapment efficiency. The optimized niosomal formulation was incorporated into a hydrogel base (HPMC) and explored for physical characteristics, permeation, and dermato-kinetic study. The optimized CTZ-loaded niosomal formulation showed an average size of 403.4 ± 15.6 nm, zeta potential of - 12.9 ± 1.7 mV, and entrapment efficiency percentage of 52.8 ± 1.9%. Compared to plain drug solution, entrapment of CTZ within niosomes significantly prolonged drug release up to 12 h. Most importantly, skin deposition studies and dermato-kinetic studies verified superior skin deposition/retention of CTZ from CTZ-loaded niosomal gels, compared to plain CTZ gel. CTZ-loaded niosomal gel permitted higher drug deposition percentage (19.2 ± 1.9%) and skin retention (AUC 1124.5 ± 87.9 μg/mL.h) of CTZ, compared to 7.52 ± 0.7% and 646.2 ± 44.6 μg/mL.h for plain CTZ gel, respectively. Collectively, niosomes might represent a promising carrier for the cutaneous delivery of cetirizine for the topical management of alopecia.

Citing Articles

Fabrication of Thymoquinone and Ascorbic Acid-Loaded Spanlastics Gel for Hyperpigmentation: In Vitro Release, Cytotoxicity, and Skin Permeation Studies.

Zaid Alkilani A, Alkhaldi R, Basheer H, Amro B, Alhusban M Pharmaceutics. 2025; 17(1).

PMID: 39861696 PMC: 11768207. DOI: 10.3390/pharmaceutics17010048.

Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia.

Almutairy B, Khafagy E, Aldawsari M, Alshetaili A, Alotaibi H, Lila A Int J Pharm X. 2024; 7:100240.

PMID: 38577618 PMC: 10992714. DOI: 10.1016/j.ijpx.2024.100240.

Design and Evaluation of Tretinoin Fatty Acid Vesicles for the Topical Treatment of Psoriasis.

Zhao Y, Wang C, Zou B, Fu L, Ren S, Zhang X Molecules. 2023; 28(23).

PMID: 38067597 PMC: 10708007. DOI: 10.3390/molecules28237868.

Ophthalmic Bimatoprost-Loaded Niosomal In Situ Gel: Preparation, Optimization, and In Vivo Pharmacodynamics Study.

Aldawsari M, Moglad E, Alotaibi H, Alkahtani H, Khafagy E Polymers (Basel). 2023; 15(21).

PMID: 37960016 PMC: 10649908. DOI: 10.3390/polym15214336.

References

Hossein Mostafa D, Samadi A, Niknam S, Ahmad Nasrollahi S, Guishard A, Firooz A . Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. J Pharm Pharm Sci. 2021; 24:191-199. DOI: 10.18433/jpps31456. View

Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A . Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018; 10(2). PMC: 6027495. DOI: 10.3390/pharmaceutics10020057. View

Kelly Y, Blanco A, Tosti A . Androgenetic Alopecia: An Update of Treatment Options. Drugs. 2016; 76(14):1349-64. DOI: 10.1007/s40265-016-0629-5. View

Mokhtar M, Sammour O, Hammad M, Megrab N . Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008; 361(1-2):104-11. DOI: 10.1016/j.ijpharm.2008.05.031. View

Goindi S, Kumar G, Kumar N, Kaur A . Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech. 2013; 14(4):1284-93. PMC: 3840784. DOI: 10.1208/s12249-013-0017-3. View

Li D, Martini N, Wu Z, Chen S, Falconer J, Locke M . Niosomal Nanocarriers for Enhanced Dermal Delivery of Epigallocatechin Gallate for Protection against Oxidative Stress of the Skin. Pharmaceutics. 2022; 14(4). PMC: 9029719. DOI: 10.3390/pharmaceutics14040726. View

Rossi A, Campo D, Fortuna M, Garelli V, Pranteda G, De Vita G . A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. J Dermatolog Treat. 2017; 29(2):149-151. DOI: 10.1080/09546634.2017.1341610. View

Qumbar M, Ameeduzzafar , Imam S, Ali J, Ahmad J, Ali A . Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity. Biomed Pharmacother. 2017; 93:255-266. DOI: 10.1016/j.biopha.2017.06.043. View

Abdallah M, Elsewedy H, AbuLila A, Almansour K, Unissa R, Elghamry H . Quality by Design for Optimizing a Novel Liposomal Jojoba Oil-Based Emulgel to Ameliorate the Anti-Inflammatory Effect of Brucine. Gels. 2021; 7(4). PMC: 8628777. DOI: 10.3390/gels7040219. View

10.

Tavano L, Muzzalupo R, Picci N, de Cindio B . Co-encapsulation of lipophilic antioxidants into niosomal carriers: percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces. 2013; 114:144-9. DOI: 10.1016/j.colsurfb.2013.09.055. View

11.

Patel D, Dasgupta S, Dey S, Ramani Y, Ray S, Mazumder B . Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation. Sci Pharm. 2012; 80(3):749-64. PMC: 3447605. DOI: 10.3797/scipharm.1202-12. View

12.

Ghasemiyeh P, Mohammadi-Samani S . Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages. Drug Des Devel Ther. 2020; 14:3271-3289. PMC: 7429187. DOI: 10.2147/DDDT.S264648. View

13.

Moribe K, Maruyama K, IWATSURU M . Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives. Int J Pharm. 1999; 188(2):193-202. DOI: 10.1016/s0378-5173(99)00222-7. View

14.

Abdallah M, Lila A, Unissa R, Elsewedy H, Elghamry H, Soliman M . Brucine-Loaded Ethosomal Gel: Design, Optimization, and Anti-inflammatory Activity. AAPS PharmSciTech. 2021; 22(8):269. DOI: 10.1208/s12249-021-02113-8. View

15.

Pardakhty A, Varshosaz J, Rouholamini A . In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2006; 328(2):130-41. DOI: 10.1016/j.ijpharm.2006.08.002. View

16.

Wang Z, He X . Dynamics of vesicle formation from lipid droplets: mechanism and controllability. J Chem Phys. 2009; 130(9):094905. DOI: 10.1063/1.3079097. View

17.

Moin A, Wani S, Osmani R, Lila A, Khafagy E, Arab H . Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer. Drug Deliv. 2021; 28(1):1626-1636. PMC: 8330732. DOI: 10.1080/10717544.2021.1958106. View

18.

Abdelkader H, Ismail S, Kamal A, Alany R . Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Pharmazie. 2010; 65(11):811-7. View

19.

Al-Mahallawi A, Abdelbary A, Aburahma M . Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015; 485(1-2):329-40. DOI: 10.1016/j.ijpharm.2015.03.033. View

20.

Suchonwanit P, Thammarucha S, Leerunyakul K . Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019; 13:2777-2786. PMC: 6691938. DOI: 10.2147/DDDT.S214907. View